December 12, 2022 - Regulatory SynAct Pharma to make strategic acquisition of Swiss biotech company TXP Pharma
December 12, 2022 - Regulatory SynAct Pharma carries out a directed share issue of SEK 80 million in connection with the acquisition of TXP Pharma
May 20, 2022 - Regulatory Bulletin from the annual general meeting in SynAct Pharma AB on May 20, 2022
May 12, 2022 - Regulatory Last day of trading in paid subscribed shares (Sw. betalda tecknade aktier) in SynAct Pharma AB
March 28, 2022 - Regulatory Bulletin from the extraordinary general meeting on March 28, 2022, in SynAct Pharma AB
March 28, 2022 - Regulatory SynAct resolves on a fully guaranteed rights issue of approximately SEK 150 million
March 9, 2022 - Regulatory The Nomination Committee proposes Kerstin Hasselgren as a new board member of SynAct Pharma AB
